The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.
Jul 9, 2020
0
1392
Early in the pandemic, many researchers feared people who contracted COVID could be reinfected very quickly. This was because several early studies showed antibodies seemed to wane after the first few months post-infection.
Nov 26, 2020
0
28
On the first day of the UK campaign for COVID-19 vaccination, there were reports of two cases of anaphylaxis—a severe, potentially life-threatening allergic reaction—within minutes of administration of the Pfizer/BioNTech ...
Apr 7, 2021
0
6
Novel interventions using virtual reality to aid individuals with autism spectrum disorder (ASD) handle common scenarios may include helping youngsters navigate air travel. This example and more are included in a Special ...
Jan 29, 2020
0
6
With the help of a mandibular advancement device (MAD), daytime sleepiness of patients with obstructive sleep apnoea can be relieved. Treatment with an MAD is not inferior to positive airway pressure (PAP) therapy with a ...
Jun 3, 2020
0
0
Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who received a novel investigational device intended to repair the defective valve experienced significant improvements in blood ...
Apr 4, 2022
0
2
Botulinum toxin—best known by the brand name Botox—is a popular treatment to reduce facial lines and wrinkles. Over the years, plastic surgeons have explored alternative approaches to maximize effectiveness while minimizing ...
Nov 6, 2020
0
3
A federal agency has issued a final report confirming its earlier finding that people who lived near a St. Louis County creek contaminated with nuclear waste could face a higher risk of developing certain types of cancer.
May 1, 2019
0
2
A new Irish survey has highlighted the need for a national policy to implement effective high-quality Fracture Liaison Services (FLS) across Irish hospitals with the aim of reducing the risk of fractures in patients.
Jan 31, 2022
0
2
Primary analysis of the Lung Cancer Mutation Consortium (LCMC) 3 study revealed that neoadjuvant atezolizumab prior to lung cancer surgery was well tolerated by patients and met its primary endpoint of 20% major pathologic ...
Jan 30, 2021
0
2
